Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

Basit Öğe Kaydı
dc.authoridYasasever, Ceren Tilgen / 0000-0002-8732-4117
dc.authorwosidVatansever, Sezai / AAY-8457-2020
dc.authorwosidCiftci, Rumeysa / B-5300-2015
dc.authorwosidOzer, Leyla / D-1578-2015
dc.authorwosidYildiz, Ibrahim / AAF-9885-2019
dc.authorwosidTastekin, Didem / AAZ-7289-2020
dc.authorwosidkarabulut, senem / AAT-3594-2020
dc.authorwosidYasasever, Ceren Tilgen / A-6547-2018
dc.contributor.authorCiftci, Rumeysa
dc.contributor.authorTas, Faruk
dc.contributor.authorAksit, Ece
dc.contributor.authorVatansever, Sezai
dc.contributor.authorKarabulut, Senem
dc.contributor.authorSen, Fatma
dc.contributor.authorTastekin, Didem
dc.date.accessioned2021-11-01T14:58:11Z
dc.date.available2021-11-01T14:58:11Z
dc.date.issued2014
dc.department[Belirlenecek]
dc.description50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2014.32.15_suppl.e11556
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2014.32.15_suppl.e11556
dc.identifier.urihttps://hdl.handle.net/11491/6504
dc.identifier.volume32en_US
dc.identifier.wosWOS:000358613200052
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthor[Belirlenecek]
dc.language.isoen
dc.publisherAmer Soc Clinical Oncology
dc.relation.ispartofJournal Of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject[No Keywords]en_US
dc.titleClinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu